KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Gross Profit (2016 - 2026)

Medtronic's Gross Profit history spans 13 years, with the latest figure at $5.8 billion for Q1 2026.

  • For Q1 2026, Gross Profit rose 4.41% year-over-year to $5.8 billion; the TTM value through Jan 2026 reached $23.0 billion, up 6.21%, while the annual FY2025 figure was $21.9 billion, 3.58% up from the prior year.
  • Gross Profit for Q1 2026 was $5.8 billion at Medtronic, down from $5.9 billion in the prior quarter.
  • Across five years, Gross Profit topped out at $5.9 billion in Q4 2025 and bottomed at $4.9 billion in Q3 2022.
  • The 5-year median for Gross Profit is $5.5 billion (2024), against an average of $5.4 billion.
  • The largest annual shift saw Gross Profit dropped 9.91% in 2022 before it rose 8.21% in 2025.
  • A 5-year view of Gross Profit shows it stood at $5.0 billion in 2022, then grew by 3.45% to $5.2 billion in 2023, then rose by 4.48% to $5.5 billion in 2024, then rose by 8.12% to $5.9 billion in 2025, then dropped by 2.44% to $5.8 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Gross Profit are $5.8 billion (Q1 2026), $5.9 billion (Q4 2025), and $5.6 billion (Q3 2025).